ClinicalTrials.Veeva

Menu

Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis (DIAGEPS)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

EBV

Treatments

Other: Serological giagnosis

Study type

Observational

Funder types

Other

Identifiers

NCT03650231
PI2017_843_0042

Details and patient eligibility

About

This study compared the performance of three automated immunoassays, Architect (Abbott), Immulite (Siemens) and Liaison (Diasorin), for Epstein-Barr virus (EBV) serology. Ninety-one serum samples collected in Amiens University Hospital were analyzed for the presence of Viral Capsid Antigen (VCA) IgG and IgM and Epstein-Barr Nuclear Antigen (EBNA) IgG. The agreement between the three assays was calculated for each marker individually and for determination of the EBV profile, based on interpretation of the combination of these three EBV markers.

Full description

This retrospective study was conducted on 91 samples collected between 2014 and 2015 for which EBV diagnosis was requested. The serological diagnosis of EBV infection was performed in the Amiens University Hospital virology laboratory (France). The median age of patients was 34 years (mean: 38 years, range: 3-82 year) with a sex ratio of 50%. Sixteen of the 91 samples concerned children (<15 years).

This study compared the performance of three automated immunoassays, Architect (Abbott), Immulite (Siemens) and Liaison (Diasorin), for Epstein-Barr virus (EBV) serology. Ninety-one serum samples collected in Amiens University Hospital were analyzed for the presence of Viral Capsid Antigen (VCA) IgG and IgM and Epstein-Barr Nuclear Antigen (EBNA) IgG. The agreement between the three assays was calculated for each marker individually and for determination of the EBV profile, based on interpretation of the combination of these three EBV markers.

Enrollment

91 patients

Sex

All

Ages

3 to 82 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with EBV diagnosis
  • Age between 3 and 82 years

Exclusion criteria

  • Patient <3 years
  • Patient > 82 years

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems